BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 28268209)

  • 1. Patterns of Eye Movement Impairment Correlate with Regional Brain Atrophy in Neurodegenerative Parkinsonism.
    Vintonyak O; Gorges M; Müller HP; Pinkhardt EH; Ludolph AC; Huppertz HJ; Kassubek J
    Neurodegener Dis; 2017; 17(4-5):117-126. PubMed ID: 28268209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional microstructural damage and patterns of eye movement impairment: a DTI and video-oculography study in neurodegenerative parkinsonian syndromes.
    Gorges M; Maier MN; Rosskopf J; Vintonyak O; Pinkhardt EH; Ludolph AC; Müller HP; Kassubek J
    J Neurol; 2017 Sep; 264(9):1919-1928. PubMed ID: 28762086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations.
    Paviour DC; Price SL; Jahanshahi M; Lees AJ; Fox NC
    Mov Disord; 2006 Jul; 21(7):989-96. PubMed ID: 16602104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Messina D; Cerasa A; Condino F; Arabia G; Novellino F; Nicoletti G; Salsone M; Morelli M; Lanza PL; Quattrone A
    Parkinsonism Relat Disord; 2011 Mar; 17(3):172-6. PubMed ID: 21236720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of smooth pursuit eye movement deficits in multiple system atrophy and Parkinson's disease.
    Pinkhardt EH; Kassubek J; Süssmuth S; Ludolph AC; Becker W; Jürgens R
    J Neurol; 2009 Sep; 256(9):1438-46. PubMed ID: 19363627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
    J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleep disturbances and brain MRI morphometry in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy - a comparative study.
    Gama RL; Távora DG; Bomfim RC; Silva CE; de Bruin VM; de Bruin PF
    Parkinsonism Relat Disord; 2010 May; 16(4):275-9. PubMed ID: 20185356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy.
    Paviour DC; Price SL; Jahanshahi M; Lees AJ; Fox NC
    Brain; 2006 Apr; 129(Pt 4):1040-9. PubMed ID: 16455792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manual MRI morphometry in Parkinsonian syndromes.
    Möller L; Kassubek J; Südmeyer M; Hilker R; Hattingen E; Egger K; Amtage F; Pinkhardt EH; Respondek G; Stamelou M; Möller F; Schnitzler A; Oertel WH; Knake S; Huppertz HJ; Höglinger GU
    Mov Disord; 2017 May; 32(5):778-782. PubMed ID: 28150443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of video-oculography in progressive supranuclear palsy: a controlled study in 100 patients.
    Wunderlich J; Behler A; Dreyhaupt J; Ludolph AC; Pinkhardt EH; Kassubek J
    J Neurol; 2021 Sep; 268(9):3467-3475. PubMed ID: 33744980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy.
    Paviour DC; Thornton JS; Lees AJ; Jäger HR
    Mov Disord; 2007 Jan; 22(1):68-74. PubMed ID: 17089396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Rusz J; Bonnet C; Klempíř J; Tykalová T; Baborová E; Novotný M; Rulseh A; Růžička E
    J Neurol; 2015; 262(4):992-1001. PubMed ID: 25683763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
    Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
    J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy.
    Schulz JB; Skalej M; Wedekind D; Luft AR; Abele M; Voigt K; Dichgans J; Klockgether T
    Ann Neurol; 1999 Jan; 45(1):65-74. PubMed ID: 9894879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI evaluation of progressive supranuclear palsy: differentiation from Parkinson's disease and multiple system atrophy.
    Eraslan C; Acarer A; Guneyli S; Akyuz E; Aydin E; Colakoglu Z; Kitis O; Calli MC
    Neurol Res; 2019 Feb; 41(2):110-117. PubMed ID: 30373485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of neurodegenerative parkinsonian syndromes by volumetric magnetic resonance imaging analysis and support vector machine classification.
    Huppertz HJ; Möller L; Südmeyer M; Hilker R; Hattingen E; Egger K; Amtage F; Respondek G; Stamelou M; Schnitzler A; Pinkhardt EH; Oertel WH; Knake S; Kassubek J; Höglinger GU
    Mov Disord; 2016 Oct; 31(10):1506-1517. PubMed ID: 27452874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal quantitative MRI in multiple system atrophy and progressive supranuclear palsy.
    Reginold W; Lang AE; Marras C; Heyn C; Alharbi M; Mikulis DJ
    Parkinsonism Relat Disord; 2014 Feb; 20(2):222-5. PubMed ID: 24239142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical speech impairment in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy.
    Sachin S; Shukla G; Goyal V; Singh S; Aggarwal V; ; Behari M
    Neurol India; 2008; 56(2):122-6. PubMed ID: 18688134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New and reliable MRI diagnosis for progressive supranuclear palsy.
    Oba H; Yagishita A; Terada H; Barkovich AJ; Kutomi K; Yamauchi T; Furui S; Shimizu T; Uchigata M; Matsumura K; Sonoo M; Sakai M; Takada K; Harasawa A; Takeshita K; Kohtake H; Tanaka H; Suzuki S
    Neurology; 2005 Jun; 64(12):2050-5. PubMed ID: 15985570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volume of Interest Analysis of Spatially Normalized PRESTO Imaging to Differentiate between Parkinson Disease and Atypical Parkinsonian Syndrome.
    Sakurai K; Imabayashi E; Tokumaru AM; Ito K; Shimoji K; Nakagawa M; Ozawa Y; Shimohira M; Ogawa M; Morimoto S; Aiba I; Matsukawa N; Shibamoto Y
    Magn Reson Med Sci; 2017 Jan; 16(1):16-22. PubMed ID: 27001391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.